Abstract View

Author(s): Sufiyan Ansari*1, Dr. G.J. Khan2

Email(s): 1ansarisufiyan038@gmail.com

Address:

    J.I.I.U’S Ali-Allana College of Pharmacy Akkalkuwa, Dist.- Nandurbar (425415) Maharashtra, India.

Published In:   Volume - 2,      Issue - 5,     Year - 2023

DOI: Not Available

 View HTML        View PDF

Please allow Pop-Up for this website to view PDF file.

ABSTRACT:
Artificial Intelligence (AI) has emerged to be a powerful force, captivating the world with its influence in various fields of science. In the medical field, AI has yet to reach its full potential. To throw light on this matter, review the current advancements, provide researched based insights, and predict some future outcomes, we have reviewed several articles related to AI and its uses in the medical field. We thus, have broadly classified the data into three major groups namely: diagnostics, pharmacy, and hospital management. This review article delves into the mesmerizing impact of AI in transforming healthcare practices and unlocking a realm of possibilities where sci-fi isn’t tagged with fiction but with reality. In the realm of diagnostics, using AI powered data sets in disease detection and diagnosis, accuracy of diagnosis has evidently increased.

Cite this article:
Sufiyan Ansari, Dr. G.J. Khan.Waving the A.I wand: Enchanting Diagnostics, Empowering Pharmacy, and Hospital Wizardry. IJRPAS, Sep-Oct 2023; 2(5): 40-48.


1.    Millions harmed each year. [Internet] Harvard T.H. Chan School of Public Health. [updated at 18-Sept-2013]. Available from: https://www.hsph.harvard.edu/news/press-releases/millions-harmed-each-year-from-unsafe-medical-care/

2.    Tang X. The role of artificial intelligence in medical imaging research. BJR Open. 2019 Nov 28;2(1):20190031. doi: 10.1259/bjro.20190031. PMID: 33178962; PMCID: PMC7594889.

3.    Ohad Oren, Bernard J Gersh, Deepak L Bhatt, Artificial intelligence in medical imaging: switching from radiographic pathological data to clinically meaningful endpoints, The Lancet Digital Health, Volume 2, Issue 9, 2020, Pages e486-e488, ISSN 2589-7500, https://doi.org/10.1016/S2589-7500(20)30160-6.

4.    Božić, Velibor. (2023). AI and Predictive Analytics. 10.13140/RG.2.2.23798.47682.

5.    Akyeramfo-Sam, Samuel, Acheampong Addo Philip, Derrick Yeboah, Nancy Candy love Nartey and Isaac Kofi Nti. “A Web-Based Skin Disease Diagnosis Using Convolutional Neural Networks.” International Journal of Information Technology and Computer Science (2019): n. page.

6.    Harmon DM, Sherawat O, Mayanja M, Wight J, Noseworthy PA. Artificial Intelligence for the Detection and Treatment of Atrial Fibrillation. Arrhythm Electrophysiol Rev. 2023 Apr 19;12:e12. doi: 10.15420/aer.2022.31. PMID: 37427304; PMCID: PMC10326669.

7.    Dubey A, Tiwari A. Artificial intelligence and remote patient monitoring in US healthcare market: a literature review. J Mark Access Health Policy. 2023 May 3;11(1):2205618. doi: 10.1080/20016689.2023.2205618. PMID: 37151736; PMCID: PMC10158563.

8.    Piette JD, Newman S, Krein SL, Marine N, Chen J, Williams DA, Edmond SN, Driscoll M, LaChappelle KM, Kerns RD, Maly M, Kim HM, Farris KB, Higgins DM, Buta E, Heapy AA. Patient-Centered Pain Care Using Artificial Intelligence and Mobile Health Tools: A Randomized Comparative Effectiveness Trial. JAMA Intern Med. 2022 Sep 1;182(9):975-983. doi: 10.1001/jamainternmed.2022.3178. PMID: 35939288; PMCID: PMC9361183

9.    Ellsworth GB, Burke LA, Wells MT, Mishra S, Caffrey M, Liddle D, Madhava M, O'Neal C, Anderson PL, Bushman L, Ellison L, Stein J, Gulick RM. Randomized Pilot Study of an Advanced Smart-Pill Bottle as an Adherence Intervention in Patients with HIV on Antiretroviral Treatment. J Acquire Immune Deific Syndr. 2021 Jan 1;86(1):73-80. doi: 10.1097/QAI.0000000000002519. PMID: 33306564; PMCID: PMC7735215.

10.    Babel A, Taneja R, Mondello Malvestiti F, Monaco A, Donde S. Artificial Intelligence Solutions to Increase Medication Adherence in Patients with Non-communicable Diseases. Front Digit Health. 2021 Jun 29;3:669869. doi: 10.3389/fdgth.2021.669869. PMID: 34713142; PMCID: PMC8521858.

11.    Wang L. Deep Learning Techniques to Diagnose Lung Cancer. Cancers (Basel). 2022 Nov 13;14(22):5569. doi: 10.3390/cancers14225569. PMID: 36428662; PMCID: PMC9688236.

12.    Paul D, Sanap G, Shenoy S, Kalyane D, Kalia K, Tekade RK. Artificial intelligence in drug discovery and development. Drug Discov Today. 2021 Jan;26(1):80-93. doi: 10.1016/j.drudis.2020.10.010. Epub 2020 Oct 21. PMID: 33099022; PMCID: PMC7577280.

13.         Kartikay Prasad, Vijay Kumar, Artificial intelligence-driven drug repurposing and structural biology for SARS-CoV-2, Current Research in Pharmacology and Drug Discovery, Volume 2, 2021, 100042, ISSN 2590-2571, https://doi.org/10.1016/j.crphar.2021.100042.

14.    Schork NJ. Artificial Intelligence and Personalized Medicine. Cancer Treat Res. 2019;178:265-283. doi: 10.1007/978-3-030-16391-4_11. PMID: 31209850; PMCID: PMC7580505.

15.         Osama Khan, Mohd Parvez, Pratibha Kumari, Samia Parvez, Shadab Ahmad, The future of pharmacy: How AI is revolutionizing the industry, Intelligent Pharmacy, Volume 1, Issue 1, 2023, Pages 32-40, ISSN 2949-866X,

16.         Murali K, Kaur S, Prakash A, Medhi B. Artificial intelligence in pharmacovigilance: Practical utility. Indian J Pharmacol. 2019 Nov-Dec;51(6):373-376. doi: 10.4103/ijp.IJP_814_19. Epub 2020 Jan 16. PMID: 32029958; PMCID: PMC6984023.

17.    Bhattamisra SK, Banerjee P, Gupta P, Mayuren J, Patra S, Candasamy M. Artificial Intelligence in Pharmaceutical and Healthcare Research. Big Data and Cognitive Computing. 2023; 7(1):10. https://doi.org/10.3390/bdcc7010010

18.    Klumpp M, Hintze M, Immonen M, Ródenas-Rigla F, Pilati F, Aparicio-Martínez F, Çelebi D, Liebig T, Jirstrand M, Urbann O, Hedman M, Lipponen JA, Bicciato S, Radan AP, Valdivieso B, Thronicke W, Gunopulos D, Delgado-Gonzalo R. Artificial Intelligence for Hospital Health Care: Application Cases and Answers to Challenges in European Hospitals. Healthcare (Basel). 2021 Jul 29;9(8):961. doi: 10.3390/healthcare9080961. PMID: 34442098; PMCID: PMC8393951.

19.    Chowdhury, Tasnim. (2021). USE OF ARTIFICIAL INTELLIGENCE (AI) IN MANAGING INVENTORY OF MEDICINE IN PHARMACEUTICAL INDUSTRY. 13. 3-15.

20.    Khanna NN, Maindarkar MA, Viswanathan V, Fernandes JFE, Paul S, Bhagawati M, Ahluwalia P, Ruzsa Z, Sharma A, Kolluri R, Singh IM, Laird JR, Fatemi M, Alizad A, Saba L, Agarwal V, Sharma A, Teji JS, Al-Maini M, Rathore V, Naidu S, Liblik K, Johri AM, Turk M, Mohanty L, Sobel DW, Miner M, Viskovic K, Tsoulfas G, Protogerou AD, Kitas GD, Fouda MM, Chaturvedi S, Kalra MK, Suri JS. Economics of Artificial Intelligence in Healthcare: Diagnosis vs. Treatment. Healthcare (Basel). 2022 Dec 9;10(12):2493. doi: 10.3390/healthcare10122493. PMID: 36554017; PMCID: PMC9777836.

Related Images:



Recent Images



Pharmacological Properties of Amomum subulatum Roxb., a Significant Medicinal Herb
Clinical Trials of Traditional Herbal Medicines in India: Current Scenario and Challenges
Synthesis of Thiourea Derivatives as Bioisosteric Structures of SERMs Pursuant to Virtual Screening
A Narrative Review of the Prevalence, Types, and Contributing Factors of Drug-Related Problems in Hospitals.
A Review on Nature’s Neglected Treasures Unveiling Medicinal Use of Common Weeds in Drug Therapy: A Statistical Survey
Implantable Drug Delivery Systems: A Comprehensive Review with Recent Advancements
Beyond Diarrhea Control: Emerging Neuroimmune and Psychobiotic Roles of Bacillus clausii
Artificial Intelligence-Enabled Quality by Design and Regulatory Science for Apixaban Orodispersible Tablets: A Critical Review of Clinical Rationale, Formulation Strategy, and Submission-Ready Documentation for Stroke Prevention
Analysis of pro inflammatory cytokinse response among hepatitis B patients co-infected with Plasmodium falciparum in Khartoum state, Sudan
Dual Incretin Agonism in Type 2 Diabetes and Obesity: Systematic Review of Tirzepatide Mechanisms and Clinical Outcomes

Tags